Sodium channel blocker
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1025400/Cv/3'> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1025400/Cv/3'> | ||
Sodium channel blockers are drugs which impair the conduction of sodium ions (Na+) through sodium channels. See also [https://en.wikipedia.org/wiki/Sodium_channel_blocker Sodium channel blocker]. | Sodium channel blockers are drugs which impair the conduction of sodium ions (Na+) through sodium channels. See also [https://en.wikipedia.org/wiki/Sodium_channel_blocker Sodium channel blocker]. | ||
| + | |||
| + | '''Intracellular''' | ||
| + | |||
| + | Drugs which block sodium channels by blocking from the intracellular side of the channel include: | ||
| + | |||
| + | Local anesthetics: lidocaine | ||
| + | |||
| + | Class I antiarrhythmic agents | ||
| + | |||
| + | Various anticonvulsants: phenytoin, oxcarbazepine (derivative of carbamazepine) | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:05, 31 January 2024
| |||||||||||
